BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3836611)

  • 1. [Effect of S-carboxymethylcysteine on the concentration of antibiotics in bronchial secretions and its therapeutic effects].
    Pirali F; Ravizzola G; Santus G; Inzoli MR; Turano A
    Arch Monaldi; 1985; 40(1-2):3-18. PubMed ID: 3836611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
    Braga PC; Bossi R; Allegra L
    Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
    Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
    Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
    Edwards GF; Steel AE; Scott JK; Jordan JW
    Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of S-carboxymethylcysteine on blood levels of amoxycillin and its diffusion through lung parenchyma and pleural exudate in the rat].
    Broccali G; Peviani N; Nusdeo O; Dorigotti L
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):58-63. PubMed ID: 7126330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum and bronchial concentrations of amoxicillin administered with a bronchial fluidizer].
    Concia E; Dos Santos C; Marone P; Sardi C; Cremaschi P
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):64-70. PubMed ID: 7126331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
    Simon N; Sampol E; Albanese J; Martin C; Arvis P; Urien S; Lacarelle B; Bruguerolle B
    Clin Pharmacol Ther; 2003 Oct; 74(4):353-63. PubMed ID: 14534522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of S-carboxymethylcysteine on the biophysical and biochemical properties of mucus in chronic bronchitics.
    Cox A; Jabbal-Gill I; Marriott C; Davis SS
    Adv Exp Med Biol; 1982; 144():423-9. PubMed ID: 7080939
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
    Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
    Castello D; Costa G; De Candussio G
    Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
    Goodman RM; Yergin BM; Sackner MA
    Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of a new drug combination in the therapy of acute and chronic bronchopneumopathies].
    Olivieri D; Pezza A; Polistina D; D'Agostino F
    Arch Monaldi; 1979; 34(1-2):29-41. PubMed ID: 554572
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of the combination prenoxidiazine-S-carboxy-methyl-cysteine].
    Alesina R; Caliandro L; Cerveri I; Scala C
    G Clin Med; 1979 Feb; 60(2):136-54. PubMed ID: 378746
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in glycoprotein composition of the tracheal submucosal glands caused by S-carboxymethylcysteine treatment].
    Takeda H; Ohkura Y; Misawa M; Yanaura S
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):19-25. PubMed ID: 6618348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-Carboxymethylcysteine (S-CMC) in bronchography technique.
    Nigam BK
    Indian J Chest Dis Allied Sci; 1981; 23(2):81-4. PubMed ID: 7298079
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mucoregulators: specificity of carbocysteine].
    Beleslin DB
    Srp Arh Celok Lek; 1989; 117(5-6):371-7. PubMed ID: 2595466
    [No Abstract]   [Full Text] [Related]  

  • 18. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML; Pavia D; Jones CJ; McQuiston TA
    Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbocysteine.
    Brown DT
    Drug Intell Clin Pharm; 1988; 22(7-8):603-8. PubMed ID: 3046890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and sputum levels of josamycin after single and multiple administrations in bronchopneumopathic patients.
    Fraschini F; Braga PC; Biella G; Scaglione F; Montoli C; Scarpazza G
    Int J Clin Pharmacol Res; 1983; 3(3):203-8. PubMed ID: 6679523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.